Antibodies against CXCL5, CXCL8 and CCL25 were all lower in previously hospitalized compared with outpatient COVID-19 convalescents (Extended Data Fig. 5a,b), and this was not linked to the therapy received during hospitalization (Supplementary Table 2). This evidence concerns the gene CCL25 and COVID-19.